Bodick Neil

Flexion Therapeutics, Inc.

Chief Scientific Officer

Avg. Two Year Performance

46% Avg. Purchase Return 21% Compound

41% Avg. Sale Return 19% Compound

Holdings: 489.84K shares

Last Three Months: 30-Jan-24 -- 29-Apr-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Major

Drugs

Two Year Chart

30-Apr-22 -- 29-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions